Biotechnology Newswire
International Guidelines Will Promote Food Safety of Plant and Animal Biotech Products
WASHINGTON-(Business Wire)-July 4, 2008 - The Biotechnology Industry Organization congratulates the Codex Alimentarius Commission for approving key guidelines to further promote the safety of products from agricultural plant and animal biotechnology. The Codex Commission took final action today at...
Advanced Biological Laboratories Patent Licensing Technologies SARL Enters U.S. Patent License Agreement With Viralliance Inc.
LUXEMBOURG & KALAMAZOO, Mich.-(Business Wire)-July 4, 2008 - ABL Patent Licensing Technologies, SARL, a subsidiary of Advanced Biological Laboratories SA (ABL) entered into a patent licensing agreement with Viralliance Inc. (VI). As per the scope of the patent license agreement, ABL has...
Vitrolife Acquires Further Shares in A.T.S.
KUNGSBACKA, Sweden-(Business Wire)-July 4, 2008 - Regulatory News: Vitrolife (STO:VITR) is acquiring a further 9 percent of the shares in A.T.S. Srl, the distributor of Vitrolife's products in Italy. Vitrolife thereby owns 60 percent of the company, with an option to acquire a further 10 percent...
Shire Ltd - Second Quarter 2008 Results Date Notification - 31 July 2008
BASINGSTOKE, England and PHILADELPHIA, July 4 PRNewswire-FirstCall — Shire Limited (LSE:SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, will announce second quarter 2008 earnings on Thursday 31 July 2008 Results press release will be issued at: 12:00 BST / 07:00 EDT...
Introgen Reduces Development Staff to Focus on Commercial Activities after ADVEXIN Regulatory Filings in U.S. and Europe
AUSTIN, Texas-(Business Wire)-July 3, 2008 - Introgen Therapeutics, Inc. (NASDAQ:INGN) today announced a re-allocation of employees to focus on regulatory review and commercial activities. After years of product development, Introgen is directing corporate spending toward regulatory review programs...
Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share
EXETER, N.H.-(Business Wire)-July 3, 2008 - Bentley Pharmaceuticals, Inc. ("Bentley") (NYSE: BNT) announced that the aggregate cash purchase price for its acquisition by Teva Pharmaceutical Industries Ltd. ("Teva") has been adjusted in accordance with the merger agreement after completion of the...
Savient Announces U.S. Court of Appeals Affirmation of the Dismissal of Securities Class Action Complaint
EAST BRUNSWICK, N.J.-(Business Wire)-July 3, 2008 - Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the United States Court of Appeals for the Third Circuit has entered a Judgment affirming the decision of the U.S. District Court for the District of New Jersey dismissing, with...
BIO Applauds U.S. Adoption for GE Corn, Cotton, Soybeans
WASHINGTON-(Business Wire)-July 3, 2008 - American farmers have adopted genetically engineered (GE) crops widely since their introduction in 1996, especially corn, cotton and soybean varieties, according to a new USDA report. USDA's Economic Research Service (ERS) report, Adoption of Genetically...
Fluxion Biosciences Wins R&D 100 Award
SOUTH SAN FRANCISCO, Calif.-(Business Wire)-July 3, 2008 - Fluxion Biosciences, a leading provider of functional cell biology systems for life science research and drug discovery, today announced that it has won a 2008 R&D 100 Award for its BioFlux(TM) 200 System. The R&D 100 Award places the...
Bio-Bridge Science Announces $2.775 Million Private Placement
OAK BROOK, Ill.-(Business Wire)-July 3, 2008 - Bio-Bridge Science, Inc. (OTCBB:BGES), a biotechnology company engaged in the commercial development of vaccines for the prevention and treatment of human infectious diseases announced today that it had closed a private placement of its investment...
Wyeth and Progenics Receive Approval from European Commission for RELISTOR for Opioid-Induced Constipation in Advanced Illness Patients
COLLEGEVILLE, Pa., & TARRYTOWN, N.Y.-(Business Wire)-July 3, 2008 - Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), today announced that the companies have received marketing approval for RELISTOR(TM) (methylnaltrexone bromide...
RegeneRx Completes Enrollment and Dosing of Phase IA Safety Trial for Potential Heart Drug
BETHESDA, Md.-(Business Wire)-July 3, 2008 - REGENERX BIOPHARMACEUTICALS, INC. (AMEX:RGN) (www.regenerx.com) announced today that it has completed enrollment and dosing of 40 healthy subjects for its Phase IA clinical trial testing RGN-352, an injectable formulation of TB4 for potential use in...
Medivation to Host Conference Call at 5 p.m. EDT Monday to Discuss Top-Line Phase 2 Study Results in Huntington's Disease
SAN FRANCISCO, July 3 PRNewswire-FirstCall — Medivation, Inc. (Nasdaq: MDVN) today announced that it will hold a teleconference at 5:00 p.m. EDT on Monday, July 7, to discuss top-line results from its randomized, double-blind, placebo-controlled Phase 2 clinical trial of dimebon(TM) in...
Today's Caregiver Magazine Celebrates 70th Fearless Caregiver Conference with Free Tickets to Boynton Event
-(Business Wire)-July 3, 2008 - Today's Caregiver magazine announced today that it will make available a limited number of tickets for family caregivers to attend the Palm Beach Fearless Caregiver Conference on July 16th at Benvenuto's in Boynton Beach. Registration and information for the limited...
PerkinElmer Second Quarter Earnings and Conference Call Notification
WALTHAM, Mass.-(Business Wire)-July 3, 2008 - PerkinElmer, Inc. (NYSE: PKI) today announced that on Thursday, July 24, 2008, after market close, the Company will release second quarter 2008 results. The Company will host a conference call to discuss the results that evening, July 24, 2008, at 5:00...
The Institut de la Vision and Iris Pharma Join Forces to Strengthen the Bond between the Private and Public Sectors, and between Industry and Academic Research
NICE, France-(Business Wire)-July 3, 2008 - The Institut de la Vision, a research center exclusively dedicated to eye diseases, has been the industry's benchmark on vision-related issues since its opening in March 2008. Consequently, it attracts a large number of industrialists looking to test the...
PerkinElmer Establishes ViaCord Research Institute(TM) to Further Cord Blood Stem Cell Advancements
WALTHAM, Mass.-(Business Wire)-July 3, 2008 - PerkinElmer, Inc., a global leader in Health Sciences and Photonics, today announced the creation of the ViaCord Research Institute(TM) (VRI(TM)) aimed at investigating new potential future uses of umbilical cord blood-derived stem cells. Led by a team...
Eniva VIBE(R) Nutraceutical Tested at Linus Pauling Micronutrient Research Institute and Found to Possess DNA Protective Properties
MINNEAPOLIS, July 3 PRNewswire — The Eniva Research Group has released results from aboratory testing by the world-famous Linus Pauling Micronutrient Research Institute at Oregon State University which demonstrated the Eniva Health Supplement VIBE(R) possessed DNA protective...
Bioheart, Inc., Board Appoints Howard J. Leonhardt Chief Executive Officer
SUNRISE, Fla., July 3 PRNewswire-FirstCall — Bioheart, Inc., (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced that its Board of...
Cell Biosciences Strengthens Management Team
PALO ALTO, Calif., July 3 PRNewswire — Cell Biosciences, Inc., a provider of ultrasensitive protein detection and characterization systems to life science researchers, today announced three key management team additions. Jason Novi was named Chief Financial Officer, with...
APP Pharmaceuticals Receives Final Approvals for Additional Dosages of Granisetron Hydrochloride Injection, USP
SCHAUMBURG, Ill.-(Business Wire)-July 3, 2008 - APP Pharmaceuticals, Inc. (Nasdaq:APPX), a leading manufacturer of multi-source and branded injectable pharmaceutical products, today announced that it has received final approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New...
Allos Therapeutics to Present at the Collins Stewart Fourth Annual Growth Conference
WESTMINSTER, Colo.-(Business Wire)-July 3, 2008 - Allos Therapeutics, Inc. (NASDAQ: ALTH), a biopharmaceutical company focused on developing and commercializing innovative small molecule drugs for the treatment of cancer, today announced that members of the Company's senior management will present a...
Resolvyx Scientific Advisors Publish First In-Vivo Data Showing Resolvins Suppress IL-23 and IL-17, Key Mediators of Inflammatory Disease
BEDFORD, Mass.-(Business Wire)-July 3, 2008 - Resolvyx Pharmaceuticals, Inc., the leading resolvin therapeutics company, today announced that a research team led by a Resolvyx scientific advisor and a company co-founder has demonstrated that the resolvin E1 (RvE1) effectively suppresses IL-23 and...
OSI Pharmaceuticals Announces Conversion Period for Convertible Notes
MELVILLE, N.Y.-(Business Wire)-July 3, 2008 - OSI Pharmaceuticals, Inc. (Nasdaq: OSIP) announced today that its 2% Convertible Senior Notes due 2025 (the "notes") are now convertible at the option of the holders and will remain convertible through September 30, 2008, the last trading day of the...
Cellectis and Regeneron Sign an Agreement Over the use of Homologous Recombination Technology
BIOCITECH, France, July 3 PRNewswire-FirstCall — Cellectis SA today announced the signature of an agreement with Regeneron Pharmaceuticals, Inc. over the use of Cellectis' patents covering certain uses of homologous recombination for the generation of innovative human therapies...
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
EXTON, Pa.-(Business Wire)-July 3, 2008 - Adolor Corporation (Nasdaq: ADLR) today issued an update on the Entereg(R) (alvimopan) Program for chronic opioid bowel dysfunction (OBD), under development in collaboration with GlaxoSmithKline (NYSE: GSK). The U. S. Food and Drug Administration (FDA) has...
GeneraMedix Inc. Receives Approval for Epoprostenol for Injection 1.5 mg
LIBERTY CORNER, N.J., July 3 PRNewswire — On June 27, 2008 GeneraMedix Inc. received approval from the U.S. Food and Drug Administration (FDA) for its Epoprostenol for Injection 1.5 mg New Drug Application (NDA). Epoprostenol for Injection 1.5 mg is indicated for the long-term...
Advanced Life Sciences Added to Russell Microcap Index
CHICAGO, July 3 PRNewswire-FirstCall — Advanced Life Sciences Holdings, Inc. (Nasdaq: ADLS), a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, cancer and respiratory diseases, today announced...
Vasogen Provides Corporate Update
MISSISSAUGA, ON, July 3 PRNewswire-FirstCall - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS) today announced that it has implemented additional restructuring plans to further reduce its cash burn rate. As previously announced, the Company has been exploring strategic alternatives that may include...
Rosetta Genomics to Present at Collins Stewart Fourth Annual Growth Conference
REHOVOT, Israel and JERSEY CITY, New Jersey, July 3 /PRNewswire-FirstCall/ — Rosetta Genomics Ltd (Nasdaq: ROSG), a leading developer of microRNA-based diagnostics and therapeutics, announced today it will present Collins Stewart Fourth Annual Growth Conference on Wednesday, July 9, at 8:30 am...
Huifeng Bio-Pharmaceutical (HFGB) Information to Be Available Through Standard & Poor's Market Access Program
XI'AN, China, July 3 Xinhua-PRNewswire-FirstCall — Huifeng Bio-Pharmaceutical Technology, Inc. (OTC Bulletin Board: HFGB), a leading developer and producer of plant extracts and pharmaceutical raw materials for use in pharmaceutical, nutraceutical and food production in China, announced...
Senesco Signs a Supply Agreement for Polyplus-transfection's Delivery System
NEW BRUNSWICK, N.J., July 3 PRNewswire-FirstCall — Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT) announced today that it has contracted with Polyplus-transfection (Illkirch, France) to supply Polyplus's "in vivo-jetPEI" for systemic delivery of Senesco's...
OncoGenex increases economic interest in lead cancer drug OGX-011
VANCOUVER, July 3 PRNewswire - OncoGenex Technologies Inc. and Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that the companies have amended their agreement and OncoGenex has elected to independently develop its lead cancer drug OGX-011. Under the amended agreement, OncoGenex is...
Senesco Chooses VGXI to Produce Factor 5A Plasmid
NEW BRUNSWICK, N.J., July 3 PRNewswire-FirstCall — Senesco Technologies, Inc. ("Senesco" or the "Company") (Amex: SNT) announced today that it has contracted with VGXI, Inc. (The Woodlands, TX) ("VGXI") to supply the plasmid portion of the Company's combination therapy consisting of the...
Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development
IRVINE, Calif., July 3 PRNewswire — Antigen Discovery Inc. ("ADI", formerly ImmPORT Therapeutics Inc.), a leader in high throughput antigen/biomarker discovery using advanced genomics and proteomics tools, announced today that the Company was awarded a Phase II SBIR from the National...
AMDL Announces Investor Relations Presentation Available on Website
TUSTIN, Calif., July 3 PRNewswire-FirstCall — AMDL, Inc. (Amex: ADL), a world leader in specialty pharmaceuticals headquartered in Tustin, Ca., with operations in Shenzhen, Jiangxi, and Jilin, China, announced today it has released its investor presentation which is available for...
Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
BASINGSTOKE, England and CAMBRIDGE Massachusetts, July 3 /PRNewswire-FirstCall/ — - Shire proposes acquisition of biotechnology company, Jerini AG for an equity purchase price of EUR328 million adding hereditary angioedema (HAE) product, FIRAZYR(R), to its Human Genetic Therapies (HGT...
Nabriva Therapeutics Announces Appointment of New CEO
VIENNA, Austria, July 3 PRNewswire — Nabriva Therapeutics, a specialist in antibiotics development, announces that Dr. George Golumbeski has been appointed as Chief Executive Officer of the Company. Dr. Golumbeski brings to the team nearly twenty years of industry experience serving...
Anadis' Cancer Related Mucositis Project Awarded with VISTECH Grant
MELBOURNE, Australia-(Business Wire)-July 2, 2008 - Anadis Ltd. (ASX:ANX; OTC:ANDIY) an Australian biopharmaceutical company has been awarded a product development grant for its Cancer-related Alimentary Mucositis project. The award was one of only three made by the VISTECH bi-national fund...
Microfluidics International Corporation Obtains New $2.5 Million Line of Credit in Support of Global Growth Strategy
NEWTON, Mass.-(Business Wire)-July 2, 2008 - Microfluidics International Corporation (OTCBB: MFIC) today announced that the Company has received a $2.5 million multi-year revolving line of credit from Silicon Valley Bank. The credit line will be used as working capital in support of the Company's...
BIO Supports Commitment to Making July 4 Energy Independence Day
WASHINGTON-(Business Wire)-July 2, 2008 - Through increased development and use of advanced biofuels combined with simple conservation strategies, the United States can extend its supply of homegrown energy and increase its energy security in 2009. The Biotechnology Industry Organization (BIO) today...
PPD Announces Second Quarter 2008 Earnings Release, Webcast and Conference Call
WILMINGTON, N.C.-(Business Wire)-July 2, 2008 - PPD, Inc. (Nasdaq: PPDI) will release its second quarter 2008 financial results on Tuesday, July 22, 2008, after the market closes. The earnings release will be available on the PPD Web site at http://www.ppdi.com, FirstCall and Business Wire. On...
GTC Biotherapeutics Receives Notice Related to Nasdaq Minimum Market Value Rule
FRAMINGHAM, Mass.-(Business Wire)-July 2, 2008 - GTC Biotherapeutics, Inc. ("GTC", Nasdaq: GTCB) has received a Staff Deficiency Letter from The Nasdaq Stock Market notifying GTC that for the last 10 consecutive trading days the aggregate market value of GTCB common stock has fallen below $50...
ARYx Therapeutics, Inc. Announces Procter & Gamble Exercises Option to End Collaboration on ATI-7505
FREMONT, Calif.-(Business Wire)-July 2, 2008 - ARYx Therapeutics, Inc., (NASDAQ:ARYX), a biopharmaceutical company, today announced that Procter & Gamble Pharmaceuticals, Inc. (P&G) has utilized a one-time thirty day cancellation option linked to the completion of a Thorough QT (TQT) study to...
ARYx Therapeutics, Inc. Announces Successful Results of QT Study on ATI-7505
FREMONT, Calif.-(Business Wire)-July 2, 2008 - ARYx Therapeutics, Inc., (NASDAQ:ARYX), a biopharmaceutical company, today announced the results of an important cardiac safety study on its prokinetic agent, ATI-7505. The overall results of a Thorough QT (TQT) study designed to demonstrate whether...
SpectraCell Laboratories Now Measures Vitamin C
HOUSTON, July 2 PRNewswire — Effective immediately, SpectraCell Laboratories now measures functional levels of Vitamin C (ascorbate) using its proprietary FIA(TM) (Functional Intracellular Analysis) technology. This test enables a clinician to diagnose specific vitamin and mineral...
Boston Scientific Announces FDA Approval for PROMUS(TM) Everolimus-Eluting Coronary Stent System
NATICK, Mass., July 2 PRNewswire-FirstCall — Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved the PROMUS(TM) Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The PROMUS Stent is...
Omrix Biopharmaceuticals Initiates Phase II Clinical Trial in Israel for Fibrin Pad Product Candidate
NEW YORK-(Business Wire)-July 2, 2008 - Omrix Biopharmaceuticals, Inc. ("Omrix" or the "Company") (NASDAQ: OMRI) announced today that it has enrolled its first patient in a Phase II clinical trial in Israel for its Fibrin Pad product candidate. This is the first clinical trial that will evaluate the...
FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
ABBOTT PARK, Ill., July 2 PRNewswire-FirstCall — Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the XIENCE(TM) V Everolimus Eluting Coronary Stent System for the treatment of coronary artery disease. XIENCE V is the only drug eluting stent to have...
Biopure Announces Private Equity Financing
CAMBRIDGE, Mass., July 2 PRNewswire-FirstCall — Biopure Corporation (Nasdaq: BPUR) announced today that it has signed an agreement with purchasers for a private placement of its common stock and warrants for up to $2.3 million in tranches, assuming no exercise of the warrants. The...
Glaucoma Surgery Studied in Medicare Patients; New Hope for People With End-Stage Glaucoma
SAN FRANCISCO-(Business Wire)-July 2, 2008 - Ophthalmologists (Eye M.D.s) continue to develop treatments to help the more than three million Americans with glaucoma. The July issue of Ophthalmology includes a large, national study of outcomes of incisional surgeries, used to reduce pressure inside...
On the Occasion of Its General Meeting, France Biotech Confirms Its Unifying Mission for All Innovative Small and Medium-Sized Life-Science Businesses in Its Statutes
PARIS-(Business Wire)-July 2, 2008 - Following its Annual General Meeting, held on Tuesday 24th June, in Paris, France Biotech, the French life sciences industry association (www.france-biotech.org), reappointed its Board of Directors according to the statutes of association. France Biotech also...
BIO to Co-Sponsor Import Safety Summit
WASHINGTON-(Business Wire)-July 2, 2008 - The Biotechnology Industry Organization (BIO) will join with 12 other trade associations to sponsor an inter-industry summit on import safety on Wednesday, July 9, 2008 in Washington, D.C. The summit will bring together a variety of industries, from food...
Providing Artificial Limbs to Amputees Leads TAPC to Be Named the "Best Place to Work" in Houston by Houston Business Journal
HOUSTON-(Business Wire)-July 2, 2008 - The Houston Business Journal recently announced that the Amputee and Prosthetic Center is the "Best Place to Work" among Houston-based companies with 1 to 100 employees. The Best Places to Work drew hundreds of nominations from various Houston companies that...
Lev Pharmaceuticals to Present at the Collins Stewart 4th Annual Growth Conference
NEW YORK-(Business Wire)-July 2, 2008 - Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that Joshua Schein, Ph.D., chief executive officer of Lev will present at the Collins Stewart 4th Annual Growth Conference, being held July 8-10 at the Mandarin Oriental Hotel in...
Simulations Plus Releases Major Software Update for Its Top Rated Predictive Software
LANCASTER, Calif.-(Business Wire)-July 2, 2008 - Simulations Plus, Inc. (NASDAQ:SLP), a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced that it has released Version 3.0 of its best-in-class ADMET Predictor software for predicting...
China Pharma Holdings, Inc. to Present at Collins Stewart Fourth Annual Growth Conference in New York on July 8, 2008 at 2:00 p.m. EDT
NEW YORK and HAIKOU CITY, China, July 2 Xinhua-PRNewswire-FirstCall — China Pharma Holdings, Inc. (''China Pharma'') (OTC Bulletin Board: CPHI) which develops, manufactures, and markets generic and branded bio- pharmaceutical products in China, today announced that the management will...
Multi-year clinical study data suggest use of FDA-cleared mobile air decontamination unit, PlasmairT2006 with HEPA-MD(TM), contributes to reducing incidence of airborne aspergillosis infection
WASHINGTON-(Business Wire)-July 2, 2008 - AirInSpace, a leading supplier of mobile devices that 'catch and inactivate' harmful and resistant biological particles from the air, announced today that data from a multi-year clinical study shows a significant reduction in aspergillosis infection rates in...
Natus Medical Acquires Schwarzer GmbH Neurology Division
SAN CARLOS, Calif.-(Business Wire)-July 2, 2008 - Natus Medical Incorporated (Nasdaq:BABY) today announced that it has acquired the neurology business of privately held Schwarzer GmbH in a cash transaction. The neurology division of Schwarzer, based in Munich, Germany, develops and markets...
CytoDyn Begins GMP Manufacturing of Its First-In-Class AIDS Drug
LOS ANGELES-(Business Wire)-July 2, 2008 - CytoDyn, Inc. (Pink Sheets: CYDY) has begun GMP manufacturing and humanization of Cytolin(C), a monoclonal antibody that uses the human immune system to control HIV infection. The murine version of this product, for which there is already considerable human...
Tang Capital Partners, LP Announces Proposal to Acquire Northstar Neuroscience, Inc.
SAN DIEGO-(Business Wire)-July 2, 2008 - Tang Capital Partners, LP today announced that it has made a proposal to acquire Northstar Neuroscience, Inc. (NASDAQ: NSTR) in a negotiated transaction for a price of $2.25 per share in cash. The text of the letter sent to the Northstar Board of Directors...
Bayer HealthCare and Maxygen Announce Hematology Agreement
LEVERKUSEN, Germany & REDWOOD CITY, Calif.-(Business Wire)-July 2, 2008 - Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's (Nasdaq:MAXY) hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII. The...
MicroIslet Provides Safety and Efficacy Data Update
SAN DIEGO-(Business Wire)-July 2, 2008 - MicroIslet Inc. (OTCBB: MIIS, http://www.microislet.com), a biotechnology company engaged in the development and commercialization of cell therapies for diabetes, is pleased to report recent safety and efficacy data. To date, MicroIslet has seen no adverse...
RegeneRx Receives Second $100,000 Award from State of Maryland to Develop Novel Treatment for Cardiac Reperfusion Injury
BETHESDA, Md.-(Business Wire)-July 2, 2008 - RegeneRx Biopharmaceuticals, Inc. (Amex:RGN) (www.regenerx.com) announced today that it received a second $100,000 award from the State of Maryland Industrial Partnerships (MIPS) program after successful completion of the first year's research goals...
PURE Bioscience Strengthens Pharmaceutical Development Program
SAN DIEGO, Calif.-(Business Wire)-July 2, 2008 - PURE Bioscience (NASDAQ: PURE) today announced the strengthening of its program to develop silver dihydrogen citrate (SDC)-based pharmaceutical products with the addition of a new development partner, FTA Therapeutics, LLC (FTA). PURE has entered into...
VLST Corporation Appoints Internationally Recognized Researcher Paul J. Carter, Ph.D. as Chief Scientific Officer
SEATTLE-(Business Wire)-July 2, 2008 - VLST Corporation, a Seattle-based biotechnology company focused on the development of therapeutics for autoimmune and inflammatory disorders, today announced that Paul J. Carter, Ph.D., a 20-year biotechnology research veteran, will join the Company as chief...
Bioheart, Inc., Added to Russell Microcap Index
SUNRISE, Fla., July 2 PRNewswire-FirstCall — Bioheart, Inc. (Nasdaq: BHRT) a biotechnology company that is focused on the development of autologous (patient-derived) cell therapies and devices for the treatment of chronic and acute heart damage, today announced it has been added to...
Transcept Pharmaceuticals Appoints Key Senior Executives
PT. RICHMOND, Calif., July 2 PRNewswire — Transcept Pharmaceuticals, Inc. today announced the appointment of Terrence Moore to the position of Vice President, Marketing and Sales and Susan Koppy to the position of Vice President, Corporate Development. Both Mr. Moore and Ms. Koppy...
Pharmacy Students Taught Improved Medication Adherence and Holistic Health Services Through Program Incorporating InforMedix's Med-eXpert(TM) System
ROCKVILLE, Md., July 2 PRNewswire-FirstCall — InforMedix Holdings, Inc. (OTC Bulletin Board: IFMX) is pleased to announce that Auburn University's Harrison School of Pharmacy has successfully incorporated InforMedix's Med-eMonitor and Med-eXpert Systems into its teaching curriculum...
Bioniche Pharma Acquires Baxter's ENLON(R) and ENLON-PLUS(R)
LAKE FOREST, Ill., July 2 PRNewswire — Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, announced today the acquisition of Baxter Healthcare Corporation's ENLON product line, including: — ENLON(R) (edrophonium chloride injection, USP) 10...
Conmed Healthcare Management, Inc. Signs Contract with Caroline County, Maryland
HANOVER, Md.-(Business Wire)-July 2, 2008 - Conmed Healthcare Management, Inc. (OTCBB:CMHM) a leading full service provider of correctional facility healthcare services to county detention centers, today announced that it has signed a one-year contract, with four one-year renewal option periods...
Research and Markets: Natural-Based Polymers for Biomedical Applications Reviews the Wealth of Research on Both Tried and Promising New Natural-Based Biomedical Polymers
DUBLIN, Ireland-(Business Wire)-July 2, 2008 - Research and Markets has announced the addition of the "Natural-based polymers for biomedical applications" report to their offering. Polymers from natural sources are particularly useful as biomaterials, given their similarity to the extracellular...
PuriCore Awarded $8.6 Million Contract
MALVERN, Pa., & STAFFORD, United Kingdom-(Business Wire)-July 2, 2008 - PuriCore plc (LSE: PURI), the life sciences company focused on the control of infectious pathogens with its novel, safe antimicrobial technology, today announced the signing of an $8.6 million agreement with its largest...
Cyclacel to Present at Collins Stewart Fourth Annual Growth Conference
BERKELEY HEIGHTS, N.J.-(Business Wire)-July 2, 2008 - Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), (NASDAQ: CYCCP) announced today that John Womelsdorf, Ph.D., Vice President, Business Development, will present an overview of the Company at the Collins Stewart 4th Annual Growth Conference taking...
Cubist Pharmaceuticals to Promote in the U.S. AstraZeneca's Broad Spectrum Antibiotic, MERREM I.V.
LEXINGTON, Mass.-(Business Wire)-July 2, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has signed an exclusive agreement with AstraZeneca (NYSE: AZN) to promote and provide other support in the United States for MERREM(R) I.V. (meropenem for injection), an established...
EPIX Pharmaceuticals to Present at the Collins Stewart Fourth Annual Growth Conference
LEXINGTON, Mass.-(Business Wire)-July 2, 2008 - EPIX Pharmaceuticals, Inc. (NASDAQ: EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that it is...
Aureus Pharma Announces Date of 2008 Annual User Symposium
PARIS, July 2 PRNewswire — Aureus Pharma, a leading provider of knowledge management solutions to accelerate discovery in the life science industry, announced today that the Aureus Pharma 2008 User Symposium will be held in Paris on October 23rd and 24th. This symposium follows last...
Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities.
BOSTON, July 2 PRNewswire — Allied Minds, a pre-seed investment corporation specializing in early stage university business ventures, Harvard University's Office of Technology Development, and Northeastern University announce the creation of CryoXtract Instruments, LLC, a new spin-out...
AlloCure Inc. Closes $14.5MM Series A Round to Develop a Stem Cell Therapy for Acute Kidney Injury
SALT LAKE CITY and HAMBURG, Germany, July 2 PRNewswire — AlloCure Inc., a biotechnology company at the forefront of innovative cell therapies for the treatment of acute kidney injury, today announced the closing of a $14.5MM Series A financing. The round was led by SV Life Sciences with...
Sequenom Announces Exercise in Full of Underwriters' Option to Purchase Additional Shares
SAN DIEGO-(Business Wire)-July 2, 2008 - Sequenom, Inc. (NASDAQ:SQNM) today announced that the underwriters of its previously announced common stock offering that priced on June 25, 2008 have exercised in full an option to purchase an additional 825,000 shares of its common stock. Including the...
Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML)
TORONTO, July 2 PRNewswire-FirstCall - Lorus Therapeutics Inc. (TSX: LOR, AMEX: LRP) ("Lorus" or the "Corporation"), a biopharmaceutical company specializing in the research and development of pharmaceutical products and technologies for the management of cancer, today announced publication...
Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing
VANCOUVER, British Columbia, July 2 PRNewswire — Neovasc Inc. (TSXV: NVC), formerly Medical Ventures Corp. (TSXV: MEV), a company developing and marketing innovative specialty vascular devices, today announced its name change and the expansion of its product portfolio, as the company...
MS Drug Development Agreement Based on WEHI's Medicinal Chemistry
MELBOURNE, Australia, July 2 PRNewswire — Research conducted at The Walter and Eliza Hall Institute (WEHI) has contributed significantly to a major licensing agreement signed between Australian biotechnology company, Bionomics, (ASX:BNO) and Germany-based pharmaceutical company, Merck...
Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors
REDWOOD CITY, Calif., July 2 PRNewswire — Pearl Therapeutics, Inc., a biopharmaceutical company developing products for major respiratory diseases, today announced that it has completed the closing of an $18 million round of financing. This financing was executed as an extension to...
PainReform Licenses a Novel Sustained Release Formulation of Ropivacaine from Encore Therapeutics Inc.
TEL AVIV, Israel & CARLSBAD, Calif.-(Business Wire)-July 2, 2008 - PainReform and Encore Therapeutics today announced that the two companies have entered into a licensing and development agreement related to Encore Therapeutics' ETI-211 product for the treatment of post surgical pain. The...
Bayer HealthCare and Maxygen Announce Hematology Agreement
LEVERKUSEN, Germany & REDWOOD CITY, Calif.-(Business Wire)-July 2, 2008 - Bayer HealthCare is expanding its commitment to hemophilia with the acquisition of Maxygen's (NASDAQ:MAXY) hemophilia program assets, including a next-generation recombinant Factor VIIa protein known as MAXY-VII. The...
WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR
SHANGHAI, China, July 2 Xinhua-PRNewswire — WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, today announced that it has appointed Mr. Bob Zhu as Vice...
Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products
KENILWORTH, N.J., July 2 PRNewswire-FirstCall — Schering-Plough Corporation (NYSE: SGP) today announced the successful closing of its previously announced transaction with Virbac, S.A. to divest animal health products from selected franchises. These divestments were requested by the...
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
GERMANTOWN, Md., July 1 PRNewswire-FirstCall — MiddleBrook Pharmaceuticals, Inc. (Nasdaq: MBRK), a pharmaceutical company focused on developing and commercializing novel anti-infective products, today announced that its Board of Directors has completed its previously announced review of...
ZOLL Medical Honored by Premier Healthcare Alliance for Exceptional Supplier Performance
CHELMSFORD, Mass.-(Business Wire)-July 1, 2008 - ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced today that it is a winner of the third annual Pinnacle Award, presented by the Premier Healthcare Alliance's Purchasing...
PharmaNet Development Group, Inc. to Announce Second Quarter 2008 Financial Results on July 31, 2008
PRINCETON, N.J.-(Business Wire)-July 1, 2008 - PharmaNet Development Group, Inc. (the "Company") (NASDAQ: PDGI), a leading provider of clinical development services, today announced that it will release its second quarter 2008 financial results on Thursday, July 31, 2008, before the market opens...
Teva Provides Update on Generic Seroquel(R) Litigation
JERUSALEM-(Business Wire)-July 1, 2008 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of New Jersey has issued a decision in its litigation over the Company's Abbreviated New Drug Application (ANDA) to market its generic version...
4th Annual Albert Szent-Gyorgyi Prize for Progress in Cancer Research Accepting Nominations
BETHESDA, Md.-(Business Wire)-July 1, 2008 - The National Foundation for Cancer Research announced that it is accepting nominations for the science prize to honor their co-founder, Nobel-Laureate, Dr. Albert Szent-Gyorgyi. The 4th Annual Albert Szent-Gyorgyi Prize for Progress in Cancer Research...
Microfluidic Systems Receives Continued Funding From the Department of Homeland Security (DHS) Toward the Commercial Production of Autonomous Airborne Pathogen Detection Systems
FREMONT, Calif., July 1 PRNewswire — Microfluidic Systems Inc. (MFSI) announced today that it has been awarded the Phase 3X agreement for the production of Microfluidic - Bioagent Autonomous Networked Detector (M-BAND). This award is the fourth in a series of funded phases by the DHS...
McKesson Opens Shared Service Center in Wales, UK, Creating 300 Jobs
SAN FRANCISCO-(Business Wire)-July 1, 2008 - McKesson Corp., the world's leading healthcare services provider, is opening a shared service center in Bangor, Wales, UK to support integrated payroll and human resources for the UK National Health Service (NHS), the world's largest healthcare operation...
nSpire Health Awarded Three-Year Agreement with Premier Group Purchasing Organization
LOUISVILLE, Colo.-(Business Wire)-July 1, 2008 - nSpire Health announced today a three-year contract with Premier Group Purchasing. The dual source agreement offers Premier customer hospitals and clinics exclusive access to nSpire Health's broad range of respiratory products and services...
Remedy Compensation Consulting Has Selected MarketPay as a Preferred Partner
SAN DIEGO-(Business Wire)-July 1, 2008 - Remedy Compensation Consulting has selected MarketPay as a preferred partner in the automation of survey participation and market analysis. Bruce Spiegel, Managing Director of Remedy's Survey Practice, said: "Remedy is committed to establishing and...
LCGC's PharmSep: Increasing Productivity via Fast Separations and Advanced Chromatography
ISELIN, N.J.-(Business Wire)-July 1, 2008 - LCGC magazine, the leading information provider and most trusted source among chromatographers, has announced PharmSep, a Premiere Symposium for Separation Scientists in Pharmaceuticals, and will focus on fast separations and advanced chromatography to...
Addrenex Pharmaceuticals Licenses New Compound to Sciele Pharma for the Treatment of Hypertension and Other Potential Indications
DURHAM, N.C., July 1 PRNewswire — Two years after Addrenex Pharmaceuticals set it sights on building a new class of drugs to regulate "adrenergic excess," the small Durham company has signed its second major deal with Sciele Pharma, this time to co-develop a new compound for...
Metabasis to Present at the Collins Stewart 4th Annual Growth Conference
SAN DIEGO-(Business Wire)-July 1, 2008 - Metabasis Therapeutics (Nasdaq: MBRX), announced today that Dr. Paul Laikind, president and chief executive officer, will present at the Collins Stewart 4th Annual Growth Conference at the Mandarin Oriental Hotel in New York, NY. Dr. Laikind is scheduled to...
Automating DNA Isolation From Cereal Crops With Tecan's Magnetic Bead Technology
DURHAM, N.C.-(Business Wire)-July 1, 2008 - Molecular biologists at the Research Centre for Agriculture and Forestry Laimburg in Northern Italy, have developed a semi-automated procedure for extracting and isolating high quality DNA from cereal crops, using the Te-MagS(TM) magnetic separation module...
Fourth Annual Symposium on Liver-Directed Microsphere Therapy Raises Awareness of the Latest Advances for Treating Metastatic Liver Tumors
WILMINGTON, Mass.-(Business Wire)-July 1, 2008 - More than 170 physicians and health care professionals specializing in the treatment of liver metastases gathered May 2-3 in Chicago for the fourth annual clinical symposium on liver-directed microsphere therapy. The symposium, sponsored by the Goshen...
Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction
CHAPEL HILL, N.C., July 1 PRNewswire — To effectively measure customer satisfaction, follow-up CSR phone surveys garnered the highest rating of 3.93 out of 5 among customer service and call center executives in a member-driven research study conducted by Best Practices, LLC's GLOBAL...
Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
WOODCLIFF LAKE, N.J., July 1, 2008 PRNewswire — Eisai Corporation of North America today announced the preliminary efficacy data from a trial initiated in 2002 comparing Dacogen(R) (decitabine) to Best Supportive Care (BSC) in elderly patients with myelodysplastic syndromes (MDS). The...
Premier Research Group Earns ISO 13485 Certification for Medical Device Operations
LONDON-(Business Wire)-July 1, 2008 - Premier Research Group Limited, the international pharmaceutical services company, announces that its subsidiary, Premier Research Group SA, has earned ISO 13485:2003 certification in support of its global medical device operations. ISO 13485:2003 is a...
Biotech Remains Upbeat in Wake of Market Turmoil, Burrill Analysis Finds
SAN FRANCISCO-(Business Wire)-July 1, 2008 - The biotech industry's report card for the first half of the year contains surprisingly good grades for its performance on the capital markets, and for partnering and venture capital deal making, but all other forms of financing didn't fare as well...
CET Life Sciences Center Welcomes Belmont University School of Pharmacy as New Tenant
NASHVILLE, Tenn., July 1 PRNewswire — Cumberland Emerging Technologies, Inc. (CET) today announced that Belmont University has established the Belmont School of Pharmacy Department of Pharmaceutical Sciences Laboratory at the CET Life Sciences Center. The Life Sciences Center, which...
General Data Launches Web Site to Showcase Healthcare Technology Solutions
CINCINNATI-(Business Wire)-July 1, 2008 - General Data Company, Inc. (www.general-data.com) today announces the launch of a new healthcare-focused Web site, www.general-data.com/healthcare. Delivering timely information to enhance patient safety in medical facilities, the site will provide...
VGX Pharmaceuticals receives FDA approval of IND for novel DNA vaccine for cervical cancer therapy
BLUE BELL, Pa.-(Business Wire)-July 1, 2008 - VGX Pharmaceuticals, Inc. (VGX) announced today that the U.S. Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for its DNA vaccine for cervical cancer therapy, VGX-3100. The Company expects to...
Culligan's New Aqua-Cleer(R) Advanced Drinking Water System Provides Clean, Quality Water Customized for Every Home
CHICAGO-(Business Wire)-July 1, 2008 - Over two-thirds (67%) of Americans are generally concerned about the quality of their household water supply, according to a 2008 National Consumer Water Quality Association (WQA) Research survey. News headlines warning of contaminants(1) (i.e. lead, radium...
BioTrove, Gene Express Awarded NIH Grant to Develop Novel Standardized Genetic Profiling Test
WOBURN, Mass. & WILMINGTON, N.C.-(Business Wire)-July 1, 2008 - BioTrove, Inc. and Gene Express, Inc. today announced their receipt of a two-year National Institutes of Health (NIH) grant, awarded in support of their proposed novel research of genetic biomarkers for lung cancer. Part of the...
Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
PHILADELPHIA, July 1 PRNewswire-USNewswire — The Delaware Valley Innovation Network (DVIN) announced today the award of its first Innovation Investment Grant. The Wistar Institute will receive $89,000 to support the Wistar Biomedical Technician Training (BTT) Program, a two-year...
Cubist Pharmaceuticals to Announce Second Quarter 2008 Financial Results on Thursday, July 17, 2008
LEXINGTON, Mass.-(Business Wire)-July 1, 2008 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) will issue its second quarter 2008 financial results at 4:00 p.m. EDT on Thursday, July 17th, 2008. In connection with this announcement, Cubist will host a conference call and live audio webcast (with...
Following Success of Pilot, Cenix BioScience Takes on Second RNAi-Based Target Validation Project for CellCentric
DRESDEN, Germany-(Business Wire)-July 1, 2008 - Cenix BioScience GmbH (Dresden), the leading specialist in advanced RNA interference (RNAi)-based research services, today announced that it has initiated a second target validation project under the framework research agreement signed previously...
China Clinical Development Summit to Bring Together Global Pharma, Biotech, and CROs at First-Ever Industry Conference & Exhibition on November 9-11 in Shanghai
SHANGHAI, China-(Business Wire)-July 1, 2008 - The worldwide pharmaceutical, biotech, and clinical research organization (CRO) industries will gather in Shanghai this November 9-11 to attend the industry-focused conference covering China's fast-growing clinical development industry. "CHINA TRIALS...
Biomet, Inc. Announces Completion of Its Registered Exchange Offers
WARSAW, Ind.-(Business Wire)-July 1, 2008 - Biomet, Inc. today announced the completion of exchange offers for all of its outstanding 10% Senior Notes due 2017, 10 3/8%/11 1/8% Senior Toggle Notes due 2017 and 11 5/8% Senior Subordinated Notes due 2017, which are not registered under the...
VioQuest Pharmaceuticals Submits 510(k) Application to FDA for Xyfid(TM), a Novel Topical Agent for the Treatment of Various Skin Disorders
BASKING RIDGE, N.J.-(Business Wire)-July 1, 2008 - VioQuest Pharmaceuticals (OTCBB: VOQP) today announced the submission of a 510(k) application to the United States Food and Drug Administration (FDA). The application seeks marketing clearance for Xyfid(TM) (1% uracil topical), a topical skin...
DHL Expands Temperature Controlled Freight Services in North America and Europe
PLANTATION, Fla.-(Business Wire)-July 1, 2008 - DHL Global Forwarding, the world's leading air and ocean freight service provider, continues to enhance its global capabilities for the life science and healthcare industries by expanding its network of Envirotainer QEP certified sites. The proper...
arGentis Files Patent on Nucleic Acid Sequences and Polymorphisms Predictive of Patient Responses to ARG201 an Immunotherapy for Late Phase Systemic Sclerosis
MEMPHIS, Tenn.-(Business Wire)-July 1, 2008 - arGentis Pharmaceuticals, LLC announced today that it has filed a patent application for Nucleic Acid Sequences highly associated with the inability of oral immune tolerance to be induced in some systemic sclerosis (SSc) patients. As explained in the...
Hospitals, Healthcare Providers to Save with Premier's Healthcare Alliance Agreements for Advanced Wound Care
CHARLOTTE, N.C.-(Business Wire)-July 1, 2008 - Premier Purchasing Partners, LP, today announced a new portfolio of agreements for advanced wound care with 3M Co. of St. Paul, Minn.; ConvaTec of Skillman, N.J.; Covidien of Mansfield, Mass.; Ferris Manufacturing (a veteran-owned business) of Burr...
Synthetic Blood International Changes Name to Oxygen Biotherapeutics, Inc.
COSTA MESA, Calif.-(Business Wire)-July 1, 2008 - Effective today, Oxygen Biotherapeutics, Inc. is the new name for the company previously known as Synthetic Blood International, Inc. (OTCBB:SYBD). Effective with the opening of trading today, the company's new trading symbol will be OXBO. It will...
CPEX Pharmaceuticals Shares to Begin Trading Today Following Spin-off from Bentley Pharmaceuticals
EXETER, N.H.-(Business Wire)-July 1, 2008 - CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) completed its previously announced taxable spin-off from Bentley Pharmaceuticals, Inc. (NYSE: BNT) yesterday at 11:59 p.m. Shares of the new company will begin regular trading today on the NASDAQ Capital Market...
Bentley Pharmaceuticals Completes Spin-off of Drug Delivery Business
EXETER, N.H.-(Business Wire)-July 1, 2008 - Bentley Pharmaceuticals, Inc. (NYSE: BNT) completed the previously announced taxable spin-off of its drug delivery business, CPEX Pharmaceuticals, Inc. (NASDAQ: CPEX) yesterday at 11:59 p.m. Each Bentley stockholder received, on a pro rata basis, a...
SCOLR Pharma, Inc. Advances Extended-Release Ibuprofen with Initiation of Clinical Study
BELLEVUE, Wash.-(Business Wire)-July 1, 2008 - SCOLR Pharma, Inc. (AMEX: DDD) announced the initiation of the third of three pivotal trials to evaluate the safety and efficacy of its formulation of 12-hour extended-release (ER) ibuprofen for the over-the-counter (OTC) market. The Company expects...
Alkermes Presents Positive Data on Proprietary Molecules Targeting Opioid Receptors
CAMBRIDGE, Mass.-(Business Wire)-July 1, 2008 - Alkermes, Inc. (NASDAQ: ALKS) today announced positive preclinical results for three proprietary molecules targeting opioid receptors, including ALKS 33. Data from two preclinical studies demonstrated that the three molecules showed statistically...
Thermo Fisher Scientific Acquires Open Biosystems, Creating Unmatched RNAi Platform
WALTHAM, Mass.-(Business Wire)-July 1, 2008 - Thermo Fisher Scientific Inc., the world leader in serving science, announced today that it has acquired Open Biosystems, Inc., a provider of RNA interference (RNAi), gene expression and protein detection products for life science research and drug...
Oculus Innovative Sciences Announces Positive Results from Abstract Evaluating the Use of Microcyn(R) Technology in Treatment of Atopic Dermatitis
PETALUMA, Calif.-(Business Wire)-July 1, 2008 - Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) announced that an abstract relating to the efficacy of Microcyn(R) Technology for the treatment of atopic dermatitis was peer reviewed and presented at the Third Congress of the World Union of Wound...
IBT Laboratories Names Maureen Loftus President and Chief Operating Officer
LENEXA, Kansas, July 1 PRNewswire — IBT Laboratories, a leading global clinical-diagnostics and biomedical-research laboratory specializing in immunology and allergy assays, announced that Maureen Loftus has joined the company as president and chief operating officer. According to IBT's...
NexMed Receives Cash Infusion of $5.75 Million
EAST WINDSOR, N.J.-(Business Wire)-July 1, 2008 - NexMed, Inc. (Nasdaq: NEXM), a developer of innovative transdermal products based on the NexACT(R) drug delivery technology, today announced that it raised $5.75 million in gross proceeds from the issuance of new convertible notes due December 31...
ChemGenex Announces Submission of Non-Clinical Section of Rolling NDA for Omacetaxine
MELBOURNE, Australia & MENLO PARK, Calif.-(Business Wire)-July 1, 2008 - ChemGenex Pharmaceuticals (ASX:CXS) (NASDAQ:CXSP) announced today that it has submitted the non-clinical section of the rolling submission of a New Drug Application (NDA) for omacetaxine mepesuccinate (formerly known as...
SleepQuest to Open San Francisco Office
SAN FRANCISCO, July 1 PRNewswire — Finding relief from Obstructive Sleep Apnea (OSA) just got easier with the opening of SleepQuest's newest location in San Francisco. "We are excited to be opening a new office," said Robert Koenigsberg, President/CEO of SleepQuest, Inc. "We are well...
Frost & Sullivan Recognizes Integrity Applications for Path-Breaking Technology Innovation and Growth Potential in the Non-Invasive Glucose Monitoring Markets
PALO ALTO, Calif.-(Business Wire)-July 1, 2008 - Based on its recent analysis of the biosensors market, Frost & Sullivan recognizes Integrity Applications Ltd. with the 2008 North American Frost & Sullivan Product Innovation Leadership of the Year Award for developing the world's first...
Applera Corporation Completes Separation of its Celera Business and is Renamed Applied Biosystems Inc.
FOSTER CITY, Calif.-(Business Wire)-July 1, 2008 - Applera Corporation announced today that the name of the company has been changed to Applied Biosystems Inc. to reflect the remaining business of the company following the separation of its Celera business. Effective today, Celera Corporation...
Elixir Pharmaceuticals Announces Exclusive Sirtuin Intellectual Property License Agreement with Boston University
CAMBRIDGE, Mass.-(Business Wire)-July 1, 2008 - Elixir Pharmaceuticals, Inc., today announced the Company has entered an exclusive license agreement with Boston University to key intellectual property covering discoveries regarding the use of modulators of SIRT1, a member of the sirtuin class of...
Protalix BioTherapeutics Joins the Russell Microcap(TM) Index
CARMIEL, Israel-(Business Wire)-July 1, 2008 - Protalix BioTherapeutics, Inc. (Amex: PLX), today announced that on June 27th, 2008, the Company was added to the Russell Microcap Index as part of the Russell Investment Group's reconstitution of its family of U.S. indexes. Membership in the Russell...
Inspire Announces Webcast of Presentation at Collins Stewart Growth Conference
DURHAM, N.C.-(Business Wire)-July 1, 2008 - Inspire Pharmaceuticals, Inc. (NASDAQ: ISPH) announced today that Christy L. Shaffer, Ph.D., President and CEO of Inspire, will present at the Collins Stewart Fourth Annual Growth Conference on July 8, 2008 at 10:30 am ET in New York City. The webcast of...
N.C. Biotechnology Center Launches Industrial Fellowship Program
Companies invited to submit applications for positions RESEARCH TRIANGLE PARK, N.C., July 1 PRNewswire-USNewswire — The North Carolina Biotechnology Center has unveiled a unique fellowship program to help postdoctoral scientists from the state's research universities transition into...
Aethlon Medical Announces Second HIV/AIDS Treatment Site
SAN DIEGO-(Business Wire)-July 1, 2008 - Aethlon Medical, Inc. (OTCBB:AEMD) announced today that it has added a second HIV/AIDS clinical study location at the Bhvani Hospital in Bihar, India. Aethlon previously disclosed plans to initiate the "first-in-man" clinical study of a medical device to...
Lev Pharmaceuticals to Submit Cinryze(TM) Application to the EMEA
NEW YORK-(Business Wire)-July 1, 2008 - Lev Pharmaceuticals, Inc. ("Lev" or the "Company") (OTCBB:LEVP) announced today that it has entered into a letter agreement with the Sanquin Blood Supply Foundation ("Sanquin"), authorizing Lev to file for European marketing authorization of its lead product...
Conversion Right Triggered for LabCorp's Liquid Yield Option(TM) Notes Due 2021 and Zero Coupon Convertible Subordinated Notes Due 2021
BURLINGTON, N.C.-(Business Wire)-July 1, 2008 - Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announced today that its zero coupon subordinated Liquid Yield Option(TM) Notes due 2021 (LYONs) and Zero Coupon Convertible Subordinated Notes due 2021 (Zero Coupon Notes) may be...
Celera Corporation Separates from Applera Corporation
ALAMEDA, Calif.-(Business Wire)-July 1, 2008 - Celera Corporation (NASDAQ:CRA) today announced that it has completed its separation from Applera Corporation, and as an independent publicly traded company now holds the businesses, assets and liabilities previously attributed to the Celera Group...
Healthation Chosen by Large Canadian Third Party Administrator to Support All Employee Benefits and Claims Administration
DARIEN, Ill., July 1 PRNewswire — Healthation, a healthcare technology company, announced today they have signed a large Canadian Third Party Administrator (TPA) to a 10 year contract. The Canadian TPA will use the integrated real-time, rules-based AcceleHealth(R) benefits and claims...
Control and Regulation of Transport Phenomena in the Cardiac System is Now Available
DUBLIN, Ireland-(Business Wire)-July 1, 2008 - Research and Markets has announced the addition of the "Control and Regulation of Transport Phenomena in the Cardiac System" report to their offering. Leading researchers in the life sciences and engineers involved in research of transport phenomena...
EPIX Pharmaceuticals Announces Resubmission of New Drug Application for Vasovist(R)
LEXINGTON, Mass.-(Business Wire)-July 1, 2008 - EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, announced today that the New...
Liko Introduces Two Additions to Its 'Stat' Family of Low Friction Sheets
FRANKLIN, Mass., July 1 PRNewswire — Liko, a major supplier of patient lifts, slings and repositioning sheets for the healthcare industry, has announced two new additions to its "Stat" family of low friction transfer and repositioning sheets. Both new products, the Stat HandySheet(TM...
The Wellcome Trust Case Control Consortium (WTCCC) Selects Illumina Infinium High-Density (HD) DNA Analysis Products to Study 90,000 Samples
SAN DIEGO-(Business Wire)-July 1, 2008 - Illumina, Inc. (NASDAQ:ILMN) today announced that researchers participating in a new initiative funded by the Wellcome Trust selected Illumina's Infinium HD BeadChips to analyze 90,000 DNA samples. This new initiative aims to decipher the molecular basis of...
Ore Pharmaceuticals Files Investigational New Drug Application with FDA
GAITHERSBURG, Md.-(Business Wire)-July 1, 2008 - Ore Pharmaceuticals Inc. (NASDAQ:ORXE) announced today that it has filed an investigational new drug (IND) application with the U.S. Food and Drug Administration (FDA) for GL1001, the first clinical-stage inhibitor of the ACE2 enzyme. This orally...
FDA Grants Conditional Approval to Interventional Spine's PercuDyn(TM) System IDE Application
IRVINE, Calif.-(Business Wire)-July 1, 2008 - Interventional Spine, Inc. announced today that the U.S. Food and Drug Administration has approved the Company's investigational device exemption (IDE) application for its PercuDyn System for the treatment of degenerative disc disease (DDD). This...
Low-Power Ultra Wideband (UWB) Technology Best RFID Choice for Hospitals to Minimize Interference Threat
HUNTSVILLE, Ala., July 1 PRNewswire — Time Domain Corporation issues the following: WHAT: On Wednesday, June 25, the Journal of the American Medical Association (JAMA) published a report warning that radio frequency identification (RFID) may disrupt the operation of IV pumps and other...
ChromaDex, Inc. Announces Completion of Reverse Merger With Cody Resources, Inc.
IRVINE, Calif., July 1 PRNewswire — ChromaDex, Inc. ("ChromaDex"), today announced that effective June 20, 2008, it completed its merger with CDI Acquisition, Inc. ("CDI"), the wholly-owned subsidiary of Cody Resources, Inc. ("Cody") (OTC Bulletin Board: CDYE). The transaction enables...
Neogen Acquires Product Line From DuPont Animal Health Solutions
LANSING, Mich., July 1 PRNewswire-FirstCall — Neogen Corporation (Nasdaq: NEOG) announced today that it has acquired a product line used in animal health and hygiene applications from DuPont Animal Health Solutions (DAHS). The asset purchase includes 14 different product...
Galaxy Nutritional Foods Reports FY2008 Results
ORLANDO, Fla., July 1 PRNewswire-FirstCall — Galaxy Nutritional Foods, Inc. (OTC Bulletin Board: GXYF), a leading developer and marketer of cheese alternatives, organic dairy and other organic and natural food products, today reported operating results for the fourth quarter and...
BioMarin to Present at the Collins Stewart Growth Conference
NOVATO, Calif., July 1 PRNewswire-FirstCall — BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that Emil Kakkis, M.D., Ph.D., Chief Medical Officer of BioMarin, will present a company update at the Collins Stewart Growth Conference in New York City on Wednesday...
Pharmasset Joins Russell 3000 Index
PRINCETON, N.J., July 1 PRNewswire-FirstCall — Pharmasset, Inc. (Nasdaq: VRUS) joined the broad-market Russell 3000(R) Index when Russell Investments reconstituted its equity indexes on June 27. Pharmasset's membership in the Russell 3000, which remains in place for one year, means...
Ikaria(R) Strengthens Research & Development Team
CLINTON, N.J., July 1 PRNewswire — Ikaria Holdings, Inc., a fully integrated critical care biotherapeutics company, announced today the addition of two executives to its Research & Development division. Deborah Petrowsky, M.D., F.C.C.P. was named Vice President for Medical Affairs...
Instrumentation Laboratory to Celebrate 50th Anniversary With '50 and Forward' Program
LEXINGTON, Mass., July 1 PRNewswire-FirstCall — Instrumentation Laboratory (IL), a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and services, today announced its plan for a comprehensive, "50 and Forward" program to celebrate the...
Pressure Cycling Technology (PCT) Results in a Higher Yield of Proteins and in the Extraction of Proteins Not Previously Identified in Cancer, Stroke, and IVF Studies
SOUTH EASTON, Mass., July 1 PRNewswire-FirstCall — Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") today announced that scientists from the New York University ("NYU") School of Medicine and the Brooklyn Hospital Center presented results yesterday on advances they made in the areas of...
MedAvante Closes $20 Million Financing by Goldman Sachs, Trevi Health Ventures
HAMILTON, N.J., July 1 PRNewswire — MedAvante, Inc., the leader in centralized psychiatric patient evaluation, announced today that it has closed a $20 million financing by Goldman, Sachs & Co. and Trevi Health Ventures. MedAvante has developed an innovative platform to centralize...
Echo Therapeutics Initiates Clinical Study of Its Symphony(TM) Transdermal Continuous Glucose Monitoring System in Patients with Type 1 and Type 2 Diabetes
FRANKLIN, Mass., July 1 PRNewswire-FirstCall — Echo Therapeutics, Inc. (OTC Bulletin Board: ECTE) announced today that it has initiated a clinical study of its Symphony(TM) Transdermal Continuous Glucose Monitoring System (tCGM System) in patients with Type 1 and Type 2 diabetes. The...
Peregrine Pharmaceuticals Awarded DTRA Contract Worth up to $44.4 Million to Develop Bavituximab for Viral Hemorrhagic Fevers
TUSTIN, Calif., July 1 PRNewswire-FirstCall — Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), a clinical stage biopharmaceutical company developing monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, today announced it has entered into a five-year...
SuperGen Comments on Preliminary Efficacy Update on EORTC Phase 3 Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes
DUBLIN, Calif., July 1 PRNewswire-FirstCall — SuperGen Inc. (Nasdaq: SUPG), a pharmaceutical company dedicated to the discovery, rapid development and commercialization of therapies for solid tumors and hematological malignancies, today commented on the preliminary efficacy data from...
Industry Veterans Join Molecular Imprints' Management Team
AUSTIN, Texas, July 1 PRNewswire — Molecular Imprints, Inc., the market and technology leader of nanopatterning systems and solutions, today announced that Ben Eynon and Paul Hofemann have joined its management team. These distinguished industry veterans are assuming the roles of...
Bad News to Bad Bugs: Northern Antibiotics Develops Novel Polymyxins With Reduced Toxicity
HELSINKI, July 1 PRNewswire — The emergence of multidrug-resistant Gram-negative bacteria has necessitated the use of polymyxins as the agents of last resort despite their known nephrotoxicity. Now Northern Antibiotics Ltd, a Finnish biotech company, has developed novel polymyxin...
mtm laboratories Appoints Bob Silverman as CEO
HEIDELBERG, Germany-(Business Wire)-July 1, 2008 - mtm laboratories, a privately held biotech company globally developing, manufacturing and commercializing in vitro diagnostics for cervical cancer screening, today announced that it has appointed Bob Silverman as its new CEO. Mr Silverman has been...
Webcast Alert: Isis Pharmaceuticals Announces a Business Update Conference Call
CARLSBAD, Calif., July 1 PRNewswire-FirstCall — Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announces the following webcast: What: Isis Pharmaceuticals' business update When: Tuesday, July 1, 2008, at 10:00 a.m. ET / 7:00 a.m. PT Via internet: Simply log onto our web site...
Results Published in the Journal 'Cancer' Demonstrate that Oral Talactoferrin Alfa is Active as Monotherapy in Previously Treated Patients with Metastatic Renal Cell Carcinoma
HOUSTON, July 1 PRNewswire — Agennix Incorporated today announced the publication of final results from a Phase 2 monotherapy trial with talactoferrin alfa in patients who had failed previous treatment for advanced or metastatic renal cell carcinoma (RCC). Results from the study, which...
Silence Therapeutics Announces Board Changes
LONDON, July 1 PRNewswire — Silence Therapeutics plc (London AIM: SLN) ('the Company') today announced changes to its Board of Directors as part of the company's plan for growth. Effective today, Silence has appointed Annette Clancy and Jerry Randall as non-executive directors and...
Abbott Invests Additional $20M in Isis' Subsidiary Ibis Biosciences
CARLSBAD, Calif., July 1 PRNewswire-FirstCall — Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Abbott has invested an additional $20 million in Ibis Biosciences, Inc., an Isis subsidiary. The investment will allow Ibis to further develop the Ibis T5000(TM) Biosensor...
Monogram Biosciences to Present at the Collins Stewart Fourth Annual Growth Conference
SOUTH SAN FRANCISCO, Calif., July 1 PRNewswire-FirstCall — Monogram Biosciences, Inc. (Nasdaq: MGRM) announced today that William D. Young, CEO and Chairman, is scheduled to present an update on the company's business at the Collins Stewart LLC Fourth Annual Growth Conference on...
ADVENTRX Announces Preliminary Response Rate Data From Discontinued Phase 3 Trial of CoFactor(R)
SAN DIEGO, July 1 PRNewswire-FirstCall — ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced preliminary response rate results from its discontinued Phase 3 clinical trial of ANX-510, or CoFactor, the Company's folate-based biomodulator of 5-FU (5 fluorouracil), for the treatment...
Cancer Cells Revert to Normal at Specific Signal Threshold, Stanford Researchers Find
STANFORD, Calif.-(Business Wire)-July 1, 2008 - Cancer starts when key cellular signals run amok, driving uncontrolled cell growth. But scientists at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in...
GE Medical Imaging Technology to Aid Early Diagnosis of All Competing Olympic Athletes at the Beijing 2008 Olympic Games
BEIJING-(Business Wire)-July 1, 2008 - GE Healthcare, the US$17 billion healthcare business of General Electric Company (GE), is working with medical leaders in the Olympic Movement to advance the use of innovative medical imaging technologies to provide insight into athlete health, as well as...
Pinnacle Biologics Announces Opening of Executive Offices in Bannockburn, Illinois and the Addition of Sandra Miller to the Board of Directors
BANNOCKBURN, Ill., July 1 PRNewswire — Pinnacle Biologics, a private, full-service pharmaceutical and biotech solutions company today announced it has entered into a lease agreement to establish its headquarters in Bannockburn, Illinois. "This is another key milestone reached by...
ZOLL Medical Corporation Announces the Addition of a President
CHELMSFORD, Mass.-(Business Wire)-June 30, 2008 - ZOLL Medical Corporation (Nasdaq: GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, announced that Jonathan Rennert, 44, today joined ZOLL to serve as its President and will be primarily responsible for managing...
Highly Advanced Biotechnology from SkinCareRX Gives People Ability to Repair Years of Sun Damage at the DNA Level
SALT LAKE CITY-(Business Wire)-June 30, 2008 - Spending too much time soaking in the sun or in a tanning bed can be dangerous. The sun's ultraviolet rays, known as UVA and UVB, are damaging to the skin. Even if you don't end up with a suntan, overexposure to these rays can cause skin cancer and many...
Taro Board of Directors to Evaluate Unsolicited Tender Offer from Sun Pharmaceutical Industries Ltd.; Taro Asks Shareholders Not to Take Any Action at This Time
HAWTHORNE, N.Y.-(Business Wire)-June 30, 2008 - Taro Pharmaceutical Industries Ltd. ("Taro" or the "Company") (Pink Sheets: TAROF) said today that it would have no formal comment on the unsolicited tender offer commenced today by a subsidiary of Sun Pharmaceutical Industries Ltd. ("Sun"), for all...
Burnham Institute Researchers Link Early Stem Cell Mutation to Autism
LA JOLLA, Calif.-(Business Wire)-June 30, 2008 - In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism. The study...
Certified Diabetic Services, Inc. Closes $2 Million Equity Financing
NAPLES, Fla.-(Business Wire)-June 30, 2008 - Certified Diabetic Services, Inc. ("CDS") (Pink Sheets:CDIP), a national direct-to-consumer mail-order distributor of diabetic supplies and pharmaceutical services, announced that it has closed a $2 million private placement. The funds will be used to...
Array BioPharma to Present at the Collins Stewart 4th Annual Growth Conference
BOULDER, Colo.-(Business Wire)-June 30, 2008 - Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Collins Stewart 4th Annual Growth Conference on July 8 in New York. The public is welcome to participate in the conference...
Abviva, Inc.: New Case of Mad Cow Disease Detected in North America
LOS ANGELES-(Business Wire)-June 30, 2008 - Abviva, Inc. (OTCBB: AVVA) today announced that BioBDC International (BioBDC), Abviva's exclusive sales agent for Mad Cow diagnostic tests produced by Abviva's subsidiary company Prion Developmental Laboratories, Inc. (PDL), reported the Canadian Food...
Metabolix Announces that Mirel Bioplastics is Chosen by Labcon for New Laboratory Liquid Handling System
CAMBRIDGE, Mass.-(Business Wire)-June 30, 2008 - Metabolix, Inc. (NASDAQ: MBLX) today announced that Telles(TM), its joint venture with Archer Daniels Midland Company that produces Mirel(TM) bioplastics, has entered into an agreement to supply Mirel bioplastic resin to Labcon North America, a...
Invitrogen and the Genome Quebec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to Advance Pharmacogenomics Research
CARLSBAD, Calif. & MONTREAL-(Business Wire)-June 30, 2008 - A scientific collaboration aimed at advancing pharmacogenomics research through the development of novel methodologies and advanced reagents for targeted medical resequencing was announced today by Invitrogen Corporation...
Case Western Reserve University School of Medicine with Copernicus Therapeutics and Polgenix Receive $3.9 Million from the Ohio Department of Development
CLEVELAND-(Business Wire)-June 30, 2008 - Case Western Reserve University School of Medicine, in collaboration with Copernicus Therapeutics, Inc. and Polgenix, Inc., was selected to receive $3.9 million in funding from the Ohio Biomedical Research Commercialization Program (BRCP) as awarded by...
Novelle International Announces Spokesman Agreement With Dr. Ward Bond
BRADENTON, Fla.-(Business Wire)-June 30, 2008 - Annie Eng, founder of Novelle International, Inc., has announced that the company has entered into an agreement with noted nutrition educator and national television host Ward W. Bond, Ph.D., to promote Maqui Superberry, a super-premium antioxidant...
Colorado Confirmed as Top Bioscience State by National Rankings
DENVER-(Business Wire)-June 30, 2008 - "According to recently released national rankings, Colorado is a fertile state for bioscience and technology initiatives, and we're incredibly thrilled," says Chris Shapard, Deputy Director of the Colorado BioScience Association (CBSA). "It's nice to see...
BioSpace Launches the 2008-2009 Pharm Country(TM) Hotbed Campaign
SAN FRANCISCO, June 30 PRNewswire — BioSpace, the world's leading online bioscience job board and life science career fair company, launched this morning the 2008-2009 Pharm Country(TM) Hotbed Campaign featuring the bioscience industry in Connecticut New York, New Jersey, and...
Journal of Clinical Oncology Publishes Leukine(R) Study Demonstrating Positive Survival Outcomes in Patients with High-Risk Melanoma
WAYNE, N.J., June 30 PRNewswire-FirstCall — Bayer HealthCare Pharmaceuticals today confirmed that results of a Phase II trial were published in the July 1 edition of the Journal of Clinical Oncology. The study showed that Leukine(R) (sargramostim) demonstrated a median overall survival...
FDA Approves ACIPHEX(R) (rabeprazole sodium) 20 mg for Short-Term Treatment of GERD in Adolescents
WOODCLIFF LAKE, N.J., June 30 PRNewswire — Eisai Corporation of North America, a wholly-owned subsidiary of Tokyo-based Eisai Co., Ltd., announced today that the Food and Drug Administration (FDA) has approved ACIPHEX (rabeprazole sodium) 20 mg for the short-term (up to eight weeks...
Acusphere Announces FDA Acceptance of Imagify(TM) NDA for Detection of Coronary Artery Disease
WATERTOWN, Mass.-(Business Wire)-June 30, 2008 - Acusphere, Inc. (NASDAQ: ACUS) announced today that the New Drug Application (NDA) for approval to market its lead product candidate, Imagify(TM) (Perflubutane Polymer Microspheres for Injectable Suspension), has been accepted for review by the U.S...
Luminex Corporation Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
AUSTIN, Texas-(Business Wire)-June 30, 2008 - Luminex Corporation (NASDAQ:LMNX) announced today the closing of its underwritten public offering of 4,025,000 shares of its common stock, including 525,000 shares issued in connection with the underwriters exercise of their over-allotment option...
Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
NEW YORK, June 30 PRNewswire-FirstCall — Forest Laboratories, Inc. (NYSE: FRX), an international manufacturer and marketer of pharmaceutical products, will release its Fiscal 2009 First Quarter financial results before the U.S. stock market opens on Tuesday, July 22, 2008. Later that...
pSivida Managing Director to Ring the NASDAQ Stock Market Closing Bell on Tuesday, July 1
BOSTON & PERTH, Australia-(Business Wire)-June 30, 2008 - Global drug delivery company, pSivida Corp. (NASDAQ: PSDV, ASX: PVA, FSE: PSI) today announced that Dr. Paul Ashton, Managing Director, will ring the NASDAQ Stock Market Closing Bell on Tuesday, July 1, at 4 p.m. EDT. A live webcast of...
Sparta Systems Selected by Genzyme to Optimize Quality Assurance Processes with TrackWise
HOLMDEL, N.J., June 30 PRNewswire — Sparta Systems, Inc. (Sparta), the maker of TrackWise(R) and the market leader in enterprise quality and compliance management software, today announced that Genzyme, a world-leading biotechnology company, has selected Sparta Systems to enhance its...
Number of Shares in Elekta as of June 30, 2008
STOCKHOLM, Sweden-(Business Wire)-June 30, 2008 - Regulatory News: According to legislation, all publicly listed companies must - if the number of shares has changed during the month - publish the total number of shares in the company on the last trading day of the month. During June, 295,869 new...
FDA Approves EVOLENCE(R), a New Generation Collagen-Based Facial Filler
HERZLIYA, Israel & MORRIS PLAINS, N.J.-(Business Wire)-June 30, 2008 - The U.S. Food and Drug Administration ("FDA") today announced the approval of EVOLENCE(R) for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds. EVOLENCE(R) is a new advanced...
FDA Clears First Automated Whole Blood Processing System in U.S.
LAKEWOOD, Colo.-(Business Wire)-June 30, 2008 - Gambro BCT, Inc., soon to be known as CaridianBCT, a leading global provider of technology, products and services in automated blood collections, therapeutic systems, whole blood processes and pathogen reduction technologies, announced today that it...
HairDX Selling Genetic Baldness Test To Physicians Only
IRVINE, Calif.-(Business Wire)-June 30, 2008 - Pharmagenomics innovator HairDX, LLC (www.hairdx.com), today announced that it will only offer its genetic tests for predicting the risk of male and female hair loss through physicians. As part of its efforts to develop new pharmagenomic prescription...
NJ Biotechnology Industry Survey Sees Growth and Maturity
TRENTON, N.J.-(Business Wire)-June 30, 2008 - New Jersey's biotechnology industry continued to both grow and mature in 2007, according to the latest BioNJ industry survey. The industry expanded as measured by several important factors, with the number of public and private companies located in the...
NuPathe Reports Positive Phase I Results for NP101, a Novel Transdermal Patch for Acute Migraine
CONSHOHOCKEN, Pa.-(Business Wire)-June 30, 2008 - NuPathe Inc., a privately held specialty pharmaceutical company developing innovative products for the treatment of neurological and psychiatric diseases, announced positive Phase I results for NP101, a novel drug-device patch for acute migraine in...
Anika Therapeutics Announces Commercial Availability of MONOVISC(TM) in Europe
BEDFORD, Mass.-(Business Wire)-June 30, 2008 - Anika Therapeutics, Inc. (Nasdaq: ANIK), a leader in products for tissue protection, healing and repair based on hyaluronic acid (HA) technology, today announced that it has begun shipping MONOVISC(TM) to Europe. MONOVISC is a single-injection...
Search Our News Using Google Search
Can't find what you want? Try using Google: